Internet Archive Scholar

SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance

KOJI MUNAKATA, MAMORU UEMURA, ICHIRO TAKEMASA, MIYUKI OZAKI, MASAMITSU KONNO, JUNICHI NISHIMURA, TAISHI HATA, TSUNEKAZU MIZUSHIMA, NAOTSUGU HARAGUCHI, SHINGO NOURA, MASAKAZU IKENAGA, SHU OKAMURA (+5 others)
2014 International Journal of Oncology  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (495.4 kB)
https://web.archive.org/web/20190302204626/http://pdfs.semanticscholar.org/a96c/6e48643b199dfba7cc03e4e9b06ad8400407.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL. The file type is application/pdf.

We recently showed that liver metastatic tissue from patients with colorectal cancer (CRC) was a useful model for identifying novel, hypoxia-inducible genes and prognostic markers. We showed that the expression of secretoglobin, family 2A, member 1 (SCGB2A1) was a potential prognostic factor for CRC. Here, we further evaluated the prognostic impact and function of SCGB2A1 in 222 patients with CRC. The impact of SCGB2A1 expression on disease-free survival (DFS) and overall survival (OS) was
more » ... sed with mRNA expression profiling. The function of SCGB2A1 was analyzed by evaluating mRNA expression profiles in cells derived from patients with CRC and by testing the effects of transfecting SCGB2A1 into different CRC-derived cell lines. We evaluated the effects of SCGB2A1 on proliferation, chemosensitivity, radiation sensitivity and sphere formation. Univariate and multivariate analyses indicated that the expression of SCGB2A1 was an independent prognostic factor for CRC (p<0.05), together with lymph node metastasis (p<0.05). Enforced expression of SCGB2A1 in CRC-derived cell lines promoted proliferation (DLD1, SW480 and LoVo cells; p<0.05), decreased chemosensitivity to 5-fluorouracil and oxaliplatin (DLD1 and SW480 cell lines; p<0.05), and significantly increased the viability of irradiated cells (DLD1, SW480 and LoVo cell lines; p<0.05). SCGB2A1 expression was also correlated to cancer stemness-related genes (Wnt, Zeb1 and Twist). Consistent with this correlation, SCGB2A1 expressing cells (SW480) showed increased sphere formation (p<0.05). These results indicated that SCGB2A1 represented a novel, prognostic factor for CRC, and that expression of SCGB2A1 correlated with chemoresistance, radioresistance and cancer cell stemness.
doi:10.3892/ijo.2014.2316 pmid:24585249 fatcat:qfperp4rajc4zl6mjhjut7ztl4
Citation

KOJI MUNAKATA, MAMORU UEMURA, ICHIRO TAKEMASA, MIYUKI OZAKI, MASAMITSU KONNO, JUNICHI NISHIMURA, TAISHI HATA, TSUNEKAZU MIZUSHIMA, NAOTSUGU HARAGUCHI, SHINGO NOURA, MASAKAZU IKENAGA, SHU OKAMURA, MUTSUMI FUKUNAGA, KOHEI MURATA, HIROFUMI YAMAMOTO, YUICHIRO DOKI, MASAKI MORI. "SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance." International Journal of Oncology 44.5 (2014) 1521-1528